These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7951676)
1. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Harrington CR; Perry RH; Perry EK; Hurt J; McKeith IG; Roth M; Wischik CM Dementia; 1994; 5(5):215-28. PubMed ID: 7951676 [TBL] [Abstract][Full Text] [Related]
2. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct. Strong C; Anderton BH; Perry RH; Perry EK; Ince PG; Lovestone S Alzheimer Dis Assoc Disord; 1995; 9(4):218-22. PubMed ID: 8749611 [TBL] [Abstract][Full Text] [Related]
3. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. Ince P; Irving D; MacArthur F; Perry RH J Neurol Sci; 1991 Dec; 106(2):142-52. PubMed ID: 1802962 [TBL] [Abstract][Full Text] [Related]
4. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850 [TBL] [Abstract][Full Text] [Related]
5. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. McKenzie JE; Edwards RJ; Gentleman SM; Ince PG; Perry RH; Royston MC; Roberts GW Acta Neuropathol; 1996; 91(5):526-9. PubMed ID: 8740234 [TBL] [Abstract][Full Text] [Related]
6. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. Cheng AV; Ferrier IN; Morris CM; Jabeen S; Sahgal A; McKeith IG; Edwardson JA; Perry RH; Perry EK J Neurol Sci; 1991 Nov; 106(1):50-5. PubMed ID: 1779239 [TBL] [Abstract][Full Text] [Related]
7. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. Sergeant N; David JP; Lefranc D; Vermersch P; Wattez A; Delacourte A FEBS Lett; 1997 Aug; 412(3):578-82. PubMed ID: 9276470 [TBL] [Abstract][Full Text] [Related]
8. Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type. Gentleman SM; Williams B; Royston MC; Jagoe R; Clinton J; Perry RH; Ince PG; Allsop D; Polak JM; Roberts GW Neurosci Lett; 1992 Aug; 142(1):9-12. PubMed ID: 1407727 [TBL] [Abstract][Full Text] [Related]
9. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases. Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234 [TBL] [Abstract][Full Text] [Related]
10. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Spillantini MG; Crowther RA; Goedert M Acta Neuropathol; 1996 Jul; 92(1):42-8. PubMed ID: 8811124 [TBL] [Abstract][Full Text] [Related]
12. Analysis of paired helical filaments (PHFs) found in Alzheimer's disease using freeze-drying/rotary shadowing. Appelt DM; Balin BJ J Struct Biol; 1993; 111(2):85-95. PubMed ID: 8130039 [TBL] [Abstract][Full Text] [Related]
13. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002 [TBL] [Abstract][Full Text] [Related]
14. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Perry EK; Marshall E; Perry RH; Irving D; Smith CJ; Blessed G; Fairbairn AF Alzheimer Dis Assoc Disord; 1990; 4(2):87-95. PubMed ID: 2357341 [TBL] [Abstract][Full Text] [Related]
15. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Leake A; Perry EK; Perry RH; Jabeen S; Fairbairn AF; McKeith IG; Ferrier IN Biol Psychiatry; 1991 Feb; 29(4):357-64. PubMed ID: 1674664 [TBL] [Abstract][Full Text] [Related]
16. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Sierra M; Gelpi E; Martí MJ; Compta Y Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462 [TBL] [Abstract][Full Text] [Related]
17. Neuritic plaques in the Lewy body variant of Alzheimer disease lack paired helical filaments. Samuel W; Crowder R; Hofstetter CR; Hansen L Neurosci Lett; 1997 Feb; 223(2):73-6. PubMed ID: 9089676 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of quantitating neurofilament-immunoreactive Alzheimer's disease lesions. de la Monte SM; Wands JR J Histochem Cytochem; 1994 Dec; 42(12):1625-34. PubMed ID: 7983363 [TBL] [Abstract][Full Text] [Related]
19. What are the relations between Lewy body disease and AD? McKeith IG; Ince P; Jaros EB; Fairbairn A; Ballard C; Grace J; Morris CM; Perry RH J Neural Transm Suppl; 1998; 54():107-16. PubMed ID: 9850919 [TBL] [Abstract][Full Text] [Related]
20. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro. Shin RW; Lee VM; Trojanowski JQ J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]